| Name | Vibecotamab |
|---|
| Description | Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |